Lake Street upgraded Evolv (EVLV) to Buy from Hold with a price target of $9, up from $5.50, after the company reported a beat on both revenue and AEBITDA for Q2. The firm, which raised its 2025 revenue and AEBITDA forecasts, feels “there is a strengthening of tailwinds on the business.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVLV:
- Evolv reinstated with a Buy at TD Cowen
- Evolv Technology Reports Strong Revenue Growth Amid Losses
- Closing Bell Movers: UnitedHealth jumps 10% as Berkshire, Appaloosa buy weakness
- Evolv Technologies Announces Resignation of Chief Innovation Officer
- Evolv reports Q2 adjusted EPS (2c) vs (7c) last year